RASSF1APolymorphism A133S Is Associated with Early Onset Breast Cancer inBRCA1/2Mutation Carriers
Authors:
Open Access
- 1 January 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (1) , 22-25
Abstract
The tumor suppressor gene RASSF1A regulates cell cycle progression, apoptosis, and microtubule stability and is inactivated by promoter methylation in ∼50% of breast cancers. It has been shown previously that the polymorphism A133S in RASSF1A reduces its ability to regulate cell cycle progression and this polymorphism is associated with an increased risk of breast cancer. We analyzed the frequency of RASSF1A A133S in 190 Caucasian women without breast cancer and 653 patients with breast cancer including 138 BRCA1 and BRCA2 (BRCA1/2) mutation carriers, 395 non–BRCA1/2 mutations carriers, and 120 untested for BRCA1/2 mutations. Patients with breast cancer had a higher frequency of A133S than the controls [P = 0.017; odds ratios (OR), 1.71; 95% confidence intervals (95% CI), 1.10–2.66]. There is also a higher frequency of A133S in patients with higher familial breast cancer risk (P = 0.029; OR, 1.76; 95% CI, 1.06–2.92) and patients carrying BRCA1/2 mutations (P = 0.037, OR, 1.82; 95% CI, 1.04–3.18). Importantly, we found that the co-occurrence of a BRCA1 or BRCA2 mutation and A133S in RASSF1A was associated with earlier onset of breast cancer compared with those individuals with either a BRCA1/2 mutation or the A133S polymorphism alone (36.0 versus 42.0 years old, P = 0.002). Our data suggest that the presence of the RASSF1A A133S polymorphism is associated with breast cancer pathogenesis in general and modifies breast cancer age of onset in BRCA1/2 mutations carriers. Our results warrant a large-scale study to examine the effect of the A133S polymorphism in the development of breast and other types of cancers. [Cancer Res 2008;68(1):22–5]Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Ten Genes for Inherited Breast CancerCancer Cell, 2007
- Specificity of the Methylation-Suppressed A Isoform of Candidate Tumor Suppressor RASSF1 for Microtubule Hyperstabilization Is Determined by Cell Death Inducer C19ORF5Cancer Research, 2005
- The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complexNature Cell Biology, 2004
- Control of microtubule stability by the RASSF1A tumor suppressorOncogene, 2003
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Dominant Negative ATM Mutations in Breast Cancer FamiliesJNCI: Journal of the National Cancer Institute, 2002
- Probability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family HistoryJNCI: Journal of the National Cancer Institute, 1997
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- Hereditary Breast CancerAnnals of Medicine, 1991